Analysts Expect Motus GI Holdings, Inc. (NASDAQ:MOTS) to Post -$0.10 EPS

Equities research analysts expect that Motus GI Holdings, Inc. (NASDAQ:MOTS) will report earnings per share of ($0.10) for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Motus GI’s earnings. The highest EPS estimate is ($0.10) and the lowest is ($0.11). Motus GI reported earnings of ($0.12) per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 16.7%. The business is scheduled to report its next quarterly earnings report on Tuesday, March 15th.

According to Zacks, analysts expect that Motus GI will report full year earnings of ($0.45) per share for the current year, with EPS estimates ranging from ($0.54) to ($0.36). For the next financial year, analysts forecast that the company will report earnings of ($0.40) per share, with EPS estimates ranging from ($0.43) to ($0.34). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Motus GI.

Motus GI (NASDAQ:MOTS) last announced its earnings results on Friday, November 12th. The company reported ($0.10) earnings per share for the quarter, meeting the consensus estimate of ($0.10). Motus GI had a negative return on equity of 78.81% and a negative net margin of 5,675.00%. During the same quarter in the prior year, the business posted ($0.13) earnings per share.

Several research firms have commented on MOTS. HC Wainwright reaffirmed a “buy” rating and issued a $2.00 price target on shares of Motus GI in a report on Monday, November 15th. Piper Sandler cut their price target on Motus GI from $2.50 to $1.50 and set an “overweight” rating for the company in a report on Thursday, August 12th.

Several institutional investors and hedge funds have recently modified their holdings of MOTS. Geode Capital Management LLC raised its holdings in shares of Motus GI by 59.4% in the 2nd quarter. Geode Capital Management LLC now owns 333,925 shares of the company’s stock worth $347,000 after buying an additional 124,458 shares in the last quarter. Virtu Financial LLC acquired a new stake in Motus GI during the 1st quarter valued at $146,000. Millennium Management LLC acquired a new stake in Motus GI during the 1st quarter valued at $104,000. State Street Corp acquired a new stake in Motus GI during the 2nd quarter valued at $83,000. Finally, Squarepoint Ops LLC acquired a new stake in Motus GI during the 1st quarter valued at $68,000. 14.98% of the stock is owned by institutional investors and hedge funds.

NASDAQ:MOTS traded up $0.01 during mid-day trading on Thursday, hitting $0.51. 719,961 shares of the company’s stock traded hands, compared to its average volume of 2,327,935. The firm has a 50 day moving average of $0.65 and a two-hundred day moving average of $0.84. The company has a current ratio of 9.40, a quick ratio of 9.21 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $24.57 million, a price-to-earnings ratio of -0.89 and a beta of 2.43. Motus GI has a 12 month low of $0.46 and a 12 month high of $2.74.

About Motus GI

Motus GI Holdings, Inc is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Recommended Story: What are the benefits of a portfolio tracker?

Get a free copy of the Zacks research report on Motus GI (MOTS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Motus GI (NASDAQ:MOTS)

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.